The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck
Clinical trial NCT03057613 · COMPLETED
Trial details
- NCT number
- NCT03057613
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2020-06-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.